Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Catalyst Pharmaceuticals Inc. (CPRX)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Broadfin Capital

Kevin Kotler

5,136,264 $19,415 -25% 2.85%
2. 6,044,719 $22,849 1.23%
3.
VenBio Select Advisor

Kurt Von Emster

4,497,042 $16,999 0.78%
4.
Dorset Management

David M. Knott

553,475 $2,092 +8% 0.67%
5.
Mangrove Partners

Nathaniel August

1,677,944 $6,343 0.39%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.41 20,000 Director 140,000 2018-06-08 Filing
$3.35 1,000 Director 523,376 2018-06-07 Filing
$3.31 4,000 Director 522,376 2018-06-07 Filing
$3.74 5,000 Director 518,376 2018-06-01 Filing
$3.75 20,000 Director 120,000 2018-05-30 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.34 22,800 Officer 74,131 2015-10-23 Filing
$1.25 216,546 Director 87,636 2011-09-06 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 250,683 $948 2.2%
2. 448,264 $1,694 1.28%
3. 1,549,552 $5,858 0.52%
4. 508,600 $1,923 0.28%
5. 202,845 $767 0.04%
News See All